Skip to main content

1 Result(s)

within Kenichi Iijima Remove this filter English Remove this filter Endocrinology Remove this filter Internal Medicine Remove this filter

and

  1. Article

    Open Access

    Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

    Type 2 diabetes (T2DM) is associated with cardiovascular death, including sudden cardiac death due to arrhythmias. Patients with an implantable cardioverter-defibrillator (ICD) are also at high risk of develop...

    Shinya Fujiki, Kenichi Iijima, Masaaki Okabe, Shinichi Niwano… in Diabetes Therapy (2020)

    Download PDF (402 KB) View Article